Alex Derry

Abstract Adhirons are small, antibody-like proteins expressed in bacteria that bind to biological targets with high affinity. Since their discovery, Adhirons have been isolated against over 350 targets, and they can be used for many research applications. However, their therapeutic application is at present in its early stages, hence the interest in developing novel small molecules to mimic their effect.

Starting and running a Canadian food and beverage (F&B) business in the digital economy doesn’t only take an entrepreneur’s mindset, it requires Jacks and Jills of all trades who wear many hats – often at the same time. From managing staff, payroll, and inventory to creating unforgettable experiences for their customers, F&B operators, from the local pub manager to a nation-wide franchise CEO, must navigate increasingly scarce markets in an increasingly digitized and uncertain economy.

As part of our Canadian Business Leadership Circle, we feature conversations with CB leaders-in-residence – visionary leaders making an impact in their field whose experience and insights are shaping the future of business, innovation, science, and society.